Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$48,042,839
+$11,130,910 QoQ
Shares Held
5,982,919
+88.8% QoQ
Ownership
6.02%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Derivatives in SPRY
reported options exposure · as of Sep 30, 2023CallValue
$0
CallShares
0
PutValue
$203,742
PutShares
53,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. SPRY ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in SPRY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,192,705 | 2,520,937 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $48,042,839 | 5,982,919 | Shares | Sole | 2026-05-15 | |
| 2026-03-27 | $47,742,362 | 5,916,030 | Shares | Sole | 2026-03-31 | |
| 2026-03-17 | $47,929,901 | 5,391,440 | Shares | Sole | 2026-03-24 | |
| 2025-12-31 | $36,911,929 | 3,168,406 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $15,323,839 | 878,157 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,152,512 | 807,036 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,909,382 | 939,278 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,057,817 | 486,746 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $4,148,644 | 1,097,525 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $203,742 | 53,900 | Put | Sole | 2023-11-14 | |
| 2023-06-30 | $8,036,355 | 1,199,456 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $502,500 | 75,000 | Put | Sole | 2023-08-14 | |
| 2023-03-31 | $1,623,672 | 249,412 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $270,409 | 31,701 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,844,198 | 349,280 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,929,416 | 455,051 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $3,964,424 | 595,259 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,517,836 | 953,691 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $278,936 | 9,030 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,603,489 | 36,752 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,694,247 | 166,039 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||